(1-(5-Bromopyrimidin-2-yl)piperidin-3-yl)methanol

Catalog No.: 
ACDSRI130
CAS No.: 
1189973-29-2
Molecular Formula: 
C10H14BrN3O
Molecular Weight: 
272.15
(1-(5-Bromopyrimidin-2-yl)piperidin-3-yl)methanol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$147.00InquiryInquiry
5g97%$477.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1-(5-Bromopyrimidin-2-yl)piperidin-3-yl)methanol
IUPAC Name(1-(5-bromopyrimidin-2-yl)piperidin-3-yl)methanol
MDL No.MFCD09743703
Molecular FormulaC10H14BrN3O
Molecular Weight272.15
SMILESBrC1=CN=C(N=C1)N2CCCC(C2)CO
InChI KeyOXGIOCSHKYSFOC-UHFFFAOYSA-N
Synonym1189973-29-2 | [1-(5-Bromopyrimidin-2-yl)piperidin-3-yl]methanol | (1-(5-Bromopyrimidin-2-yl)piperidin-3-yl)methanol | SCHEMBL1839601 | DTXSID80674283 | MFCD09743703 | AKOS008228112 | DS-0235 | SB43134 | CS-0155419 | A892767
CAS No.1189973-29-2
PubChem CID46738266

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACDSRI130 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJMSY940 route compound structure diagram
    ACJMSY94032779-36-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDSRI130 route product structure diagram
    ACDSRI1301189973-29-2
Inquiry

2. ACDSRI130 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDSRI130 route product structure diagram
    ACDSRI1301189973-29-2
Inquiry

3. ACDSRI130 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDSRI130 route product structure diagram
    ACDSRI1301189973-29-2
Inquiry

Comments (0)